Recent Articles By The Author
Until signs of inflation start to ebb, I will remain cautious within my portfolio.
The pandemic-inspired trend toward office workers working at home will keep taking its toll on demand for office space, particularly in big cities.
Dynavax Technologies, Kala Pharmaceuticals and TherapeuticsMD are three names this biotech investor plans to add exposure to via covered calls.
Gold Resource Corp. should benefit as inflationary pressures rise and Travelzoo should improve as normal life returns.
Shares of Cara Therapeutics, Adverum Biotechnologies and Ardelyx Inc. all took big hits after each company announced unfavorable developments.
There are similarities between conditions more than 50 years ago and the present state of affairs that should give investors cause for concern.